Peroxisome proliferator-activated receptor γ-regulated cathepsin D is required for lipid antigen presentation by dendritic cells

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 240-247

  Nakken, Britt ^a,b,d   Varga, Tamas ^a   Szatmari, Istvan ^a   Szeles, Lajos ^a   Gyongyosi, Adrienn ^a   Illarionov, Petr A ^c   Dezso, Balazs ^b   Gogolak, Peter ^b   Rajnavolgyi, Eva ^b   Nagy, Laszlo ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CATHEPSIN D; LIPID ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SPHINGOLIPID ACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGEN PRESENTATION; ANTIGENS, CD1D; CATHEPSIN D; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; LYSOSOMES; MONOCYTES; NATURAL KILLER T-CELLS; PPAR GAMMA; SAPOSINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79960402469     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002421     Document Type: Article

References (53)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
2. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
3. α14 NKT cells by glycosylceramides. Science 278: 1626-1629.
4. Spada, F. M., Y. Koezuka, and S. A. Porcelli. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188: 1529-1534.
5. Bendelac, A. 1995. CD1: presenting unusual antigens to unusual T lymphocytes. Science 269: 185-186.
6. Park, S. H., J. H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160: 3128-3134. (Pubitemid 28164700)
7. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525. (Pubitemid 40477061)
8. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529. (Pubitemid 40477062)
9. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
10. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
11. Zhou, D., J. Mattner, C. Cantu, III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789. (Pubitemid 39601398)
12. Gadola, S. D., J. D. Silk, A. Jeans, P. A. Illarionov, M. Salio, G. S. Besra, R. Dwek, T. D. Butters, F. M. Platt, and V. Cerundolo. 2006. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203: 2293-2303.
13. Fox, L. M., D. G. Cox, J. L. Lockridge, X.Wang, X. Chen, L. Scharf, D. L. Trott, R. M. Ndonye, N. Veerapen, G. S. Besra, et al. 2009. Recognition of lysophospholipids by human natural killer T lymphocytes. PLoS Biol. 7: e1000228.
14. Gumperz, J. E., and M. B. Brenner. 2001. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13: 471-478.
15. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19: 354-364.
16. Hammond, K. J., and M. Kronenberg. 2003. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15: 683-689.
17. De Libero, G., A. P. Moran, H. J. Gober, E. Rossy, A. Shamshiev, O. Chelnokova, Z. Mazorra, S. Vendetti, A. Sacchi, M. M. Prendergast, et al. 2005. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22: 763-772. (Pubitemid 40814506)
18. Major, A. S., S. Joyce, and L. Van Kaer. 2006. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation. Trends Mol. Med. 12: 270-278.
19. Muindi, K., M. Cernadas, G. F. Watts, L. Royle, D. C. Neville, R. A. Dwek, G. S. Besra, P. M. Rudd, T. D. Butters, and M. B. Brenner. 2010. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d. [corrected] Proc. Natl. Acad. Sci. USA 107: 3052-3057.
20. Willson, T. M., M. H. Lambert, and S. A. Kliewer. 2001. Peroxisome proliferator-activated receptor γ and metabolic disease. Annu. Rev. Biochem. 70: 341-367.
21. Szatmari, I., and L. Nagy. 2008. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27: 2353-2362.
22. Szatmari, I., P. Gogolak, J. S. Im, B. Dezso, E. Rajnavolgyi, and L. Nagy. 2004. Activation of PPARγ specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21: 95-106. (Pubitemid 38925270)
23. Szatmari, I., D. Töröcsik, M. Agostini, T. Nagy, M. Gurnell, E. Barta, K. Chatterjee, and L. Nagy. 2007. PPARγ regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110: 3271-3280. (Pubitemid 350106320)
24. Schaft, N., J. Dörrie, P. Thumann, V. E. Beck, I. Müller, E. S. Schultz, E. Kämpgen, D. Dieckmann, and G. Schuler. 2005. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 174: 3087-3097. (Pubitemid 40279731)
25. Szatmari, I., A. Pap, R. Rühl, J. X. Ma, P. A. Illarionov, G. S. Besra, E. Rajnavolgyi, B. Dezso, and L. Nagy. 2006. PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203: 2351-2362.
26. van den Elzen, P., S. Garg, L. León, M. Brigl, E. A. Leadbetter, J. E. Gumperz, C. C. Dascher, T. Y. Cheng, F. M. Sacks, P. A. Illarionov, et al. 2005. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437: 906-910. (Pubitemid 41486768)
27. Bennett, K., T. Levine, J. S. Ellis, R. J. Peanasky, I. M. Samloff, J. Kay, and B. M. Chain. 1992. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22: 1519-1524.
28. Honey, K., and A. Y. Rudensky. 2003. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3: 472-482.
29. Riese, R. J., G. P. Shi, J. Villadangos, D. Stetson, C. Driessen, A. M. Lennon-Dumenil, C. L. Chu, Y. Naumov, S. M. Behar, H. Ploegh, et al. 2001. Regulation of CD1 function and NK1.1+ T cell selection and maturation by cathepsin S. Immunity 15: 909-919. (Pubitemid 34075372)
30. Liaudet-Coopman, E., M. Beaujouin, D. Derocq, M. Garcia, M. Glondu-Lassis, V. Laurent-Matha, C. Prébois, H. Rochefort, and F. Vignon. 2006. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 237: 167-179. (Pubitemid 43777078)
31. Yu, K. O., J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. 2005. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 102: 3383-3388.
32. Prigozy, T. I., O. Naidenko, P. Qasba, D. Elewaut, L. Brossay, A. Khurana, T. Natori, Y. Koezuka, A. Kulkarni, and M. Kronenberg. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664-667. (Pubitemid 32150427)
33. Hiraiwa, M., B. M. Martin, Y. Kishimoto, G. E. Conner, S. Tsuji, and J. S. O'Brien. 1997. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys. 341: 17-24.
34. Leonova, T., X. Qi, A. Bencosme, E. Ponce, Y. Sun, and G. A. Grabowski. 1996. Proteolytic processing patterns of prosaposin in insect and mammalian cells. J. Biol. Chem. 271: 17312-17320.
35. Kang, S. J., and P. Cresswell. 2004. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5: 175-181.
36. Zhou, D., C. Cantu, III, Y. Sagiv, N. Schrantz, A. B. Kulkarni, X. Qi, D. J. Mahuran, C. R. Morales, G. A. Grabowski, K. Benlagha, et al. 2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303: 523-527. (Pubitemid 38120850)
37. Yuan, W., X. Qi, P. Tsang, S. J. Kang, P. A. Illarionov, G. S. Besra, J. Gumperz, and P. Cresswell. 2007. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc. Natl. Acad. Sci. USA 104: 5551-5556.
38. Cheng, T. Y., M. Relloso, I. Van Rhijn, D. C. Young, G. S. Besra, V. Briken, D. M. Zajonc, I. A. Wilson, S. Porcelli, and D. B. Moody. 2006. Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J. 25: 2989-2999. (Pubitemid 44106752)
39. Barral, D. C., and M. B. Brenner. 2007. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 7: 929-941.
40. Chen, X., X. Wang, J. M. Keaton, F. Reddington, P. A. Illarionov, G. S. Besra, and J. E. Gumperz. 2007. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J. Immunol. 178: 6181-6190.
41. van den Elsen, P. J., T. M. Holling, H. F. Kuipers, and N. van der Stoep. 2004. Transcriptional regulation of antigen presentation. Curr. Opin. Immunol. 16: 67-75.
42. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16: 2851-2860. (Pubitemid 27226221)
43. Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19: 941-947.
44. Villard, J., B. Lisowska-Grospierre, P. van den Elsen, A. Fischer, W. Reith, and B. Mach. 1997. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337: 748-753.
45. Gerhold, D. L., F. Liu, G. Jiang, Z. Li, J. Xu, M. Lu, J. R. Sachs, A. Bagchi, A. Fridman, D. J. Holder, et al. 2002. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator- activated receptor-γ agonists. Endocrinology 143: 2106-2118. (Pubitemid 34521558)
46. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Curr. Opin. Genet. Dev. 5: 571-576.
47. Tontonoz, P., L. Nagy, J. G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
48. Chawla, A., Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R. M. Evans. 2001. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7: 48-52.
49. Atkins, K. B., and B. R. Troen. 1995. Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriol. Cell Growth Differ. 6: 871-877.
50. Szanto, A., S. Benko, I. Szatmari, B. L. Balint, I. Furtos, R. Rühl, S. Molnar, L. Csiba, R. Garuti, S. Calandra, et al. 2004. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol. 24: 8154-8166.
51. Honey, K., K. Benlagha, C. Beers, K. Forbush, L. Teyton, M. J. Kleijmeer, A. Y. Rudensky, and A. Bendelac. 2002. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3: 1069-1074.
52. Winau, F., V. Schwierzeck, R. Hurwitz, N. Remmel, P. A. Sieling, R. L. Modlin, S. A. Porcelli, V. Brinkmann, M. Sugita, K. Sandhoff, et al. 2004. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5: 169-174.
53. Heinrich, M., M. Wickel, W. Schneider-Brachert, C. Sandberg, J. Gahr, R. Schwandner, T. Weber, P. Saftig, C. Peters, J. Brunner, et al. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18: 5252-5263. (Pubitemid 29465576)